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Abstract
Background: Chronic headache is associated with disability and high utilisation of health care including
complementary and alternative medicine (CAM).
Findings: We investigated self-reported efficacy of CAM in people with chronic headache from the general
population. Respondents with possible self-reported chronic headache were interviewed by physicians experienced
in headache diagnostics. CAM queried included acupuncture, chiropractic, homeopathy, naprapathy, physiotherapy,
psychological treatment, and psychomotor physiotherapy. Sixty-two % and 73% of those with primary and
secondary chronic headache had used CAM.
Self-reported efficacy of CAM ranged from 0-43% without significant differences between gender, headache
diagnoses, co-occurrence of migraine, medication use or physician contact.
Conclusion: CAM is widely used, despite self-reported efficacy of different CAM modalities is modest in the
management of chronic headache.
Keywords: Complementary and alternative medicine, Primary chronic headache, Secondary chronic headache,
Population-based, Chronic tension-type headache, Chronic migraine, Medication-overuse headache
Introduction
Chronic headache, i.e. ≥ 15 days/month for 3 months or ≥
180 days/year affects 3-4% of the general population [1,2].
Management of chronic headache is a challenge, since
medications often do not alleviate it sufficiently. Thus,
many patients seek or are referred to complementary and
alternative medicine (CAM), such as acupuncture, chiro-
practic, homeopathy, naprapathy, physiotherapy, psycho-
logical treatment and psychomotor physiotherapy. The
use of CAM is high both in Norway and worldwide [3,4],
and about 1 of 3 uses CAM for headache in Norway [5]. A
survey among CAM providers suggests headache to be
one of the conditions where patients benefit most from
CAM management [6], but reports of treatment efficacy
from the patients are lacking.
The aim of this study was to investigate self-reported
efficacy of CAM in people with primary and secondary
chronic headache from the general population.
Findings
Methods
A cross-sectional epidemiological survey, including 30 000
persons aged 30–44 years old stratified for age and gender,
was drawn from the general population of eastern
Akershus County, Norway. A short postal questionnaire
screened for possible chronic headache (≥15days/last
month and/or ≥180 days/last year). Screening-positive
subjects were invited to a clinical interview and physical
and neurological examination conducted by neurological
residents. The criteria of the International Classification
of Headache Disorders II (ICHD-II) were used with
supplementary definitions for chronic rhinosinusitis and
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cervicogenic headache [1,2,7]. Chronic headache was de-
fined as headache ≥ 15 days/months for at least 3 months
or ≥ 180 days/year.
Medication overuse headache without other secondary
causes was classified as primary chronic headache.
The Complementary and alternative medicine (CAM)
forms queried included acupuncture, chiropractic, hom-
eopathy, naprapathy (manipulation and stretching of
joints and muscles), physiotherapy, psychological treat-
ment and psychomotor physiotherapy.
All CAM use was included independently on whether
it was reimbursed or not by the National Health Insur-
ance. Homeopathy and naprapathy is not reimbursed,
while the other CAM modalities, in some selected cases,
are partially or fully reimbursed from authorised pro-
viders. The participants were asked for ever-use, e.g.
“Have you ever tried/used/been to physiotherapy for
headache?” For questions of self-reported efficacy, par-
ticipants were asked with reference to the CAM man-
agement tried for their headache: “Did you experience
any efficacy in terms of lasting reduction of headache
frequency and/or intensity?”
A more detailed description of the material and
methods has been given elsewhere [1,2,8].
Statistics
Statistical analyses were performed using SPSS 20.00
(SPSS Inc., Chicago, IL, USA). For descriptive data, pro-
portions, means and 95% confidence intervals (CI) are
given. Pearson χ2 test was used for testing significance of
group differences for categorical data, Fisher`s exact test
was used when appropriate. Significance levels were set
at p<0.05. CI is not given when n <5.
Ethical issues
The Regional Committee for Medical Research Ethics and
the Norwegian Social Science Data Services approved the
study. All participants gave informed consent.
Results
253/405 (62%) participants with primary chronic head-
ache and 82/113 (73%) participants with secondary
chronic headache had used CAM for headache. Table 1
shows the self-reported efficacy of CAM. Very few used
homeopathy, naprapathy or psychological treatment.
No significant differences were found in self-reported
efficacy of different CAM modalities depending on gender,
chronic headache diagnoses, co-occurrence of migraine,
use of acute headache medication, use of prophylactic
medication, medication overuse or physician contact.
In the subgroup of chronic tension-type headache
(CTTH) without medication overuse acupuncture was
reported to be effective in 38% of participants with co-
occurrence of migraine compared to 11% of participants
without such co-occurrence. (χ2, p=0.011).
Discussion
Methodological considerations
We asked the participants for ever use of different CAM
modalities in headache management. The efficacy data are
based on self-reports and therefore subject to recall bias.
We are aware that personal causality, individual percep-
tion and understanding of pain in addition to belief in
certain CAM modalities could affect the subjective meas-
urement of headache relief and efficacy of CAM, i.e. pla-
cebo response. CAM efficacy was specified to the patients
to entail a reduction in the chronic headache frequency
and/or intensity. The number of data on homeopathy, na-
prapathy, and psychological treatment are low and results
should be interpreted with caution. The term “comple-
mentary and alternative medicine” refers to a wide range
of treatments that do not fall within conventional medi-
cine. Definition of CAM varies, as the modalities included
differs between therapeutic traditions, social and religious
cultures, healthcare systems and legislations. Furthermore
the field is constantly changing. This is also reflected in
the US National Center for Complementary and Alterna-
tive Medicine definition of CAM as “a group of diverse
medical and health care systems, practices, and products
that are not presently considered to be part of conven-
tional medicine” [9]. The prevalence of CAM use in the
general population in Norway is lower than in Asia, US
and Australia, but may be comparable to other north- and
central European countries [3,4,10]. Treatment by a
psychologist is in Norway generally not prescribed for
headache except for patients who have a clear co-morbid
illness within the psychiatric disorder spectrum. It is simi-
lar to the other CAM modalities here in that patients with
few exceptions have to carry the all costs of this treatment
themselves.
We have used the ICHD-II classification for headache
diagnoses. The general aspects, limitations and strengths of
this study have been discussed in details elsewhere [1,2,8].
Results discussion
The use of CAM is high [11,12], and this indicates that
people with chronic headache like other chronic pain suf-
ferers are likely to use CAM as a treatment option [13,14].
Other studies have found that 40–90% of chronic
headache sufferers in headache clinics use CAM for
their headache, and that chronic headache sufferers are
more likely to use CAM than episodic headache suf-
ferers [15-17].
Although the use is high, the self-reported efficacy in
our study is modest. This corresponds well with the
results of two Italian studies [15,16]. Others have
reported that medication-overuse headache patients
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Table 1 Self-reported efficacy of complementary and alternative medicine in people with primary and secondary chronic headache
CTTH without
medication
overuse % (95% CI)
n/N
CTTH with
medication
overuse % (95% CI)
n/N
CM %
(95% CI)
n/N
Other primary
chronic headache
% (95% CI)
n/N
All primary
chronic headache
% (95% CI)
n/N
CPTH %
(95% CI)
n/N
CEH %
(95% CI)
n/N
HACRs %
(95% CI)
n/N
Other secondary
chronic headache
% (95% CI)
n/N
All secondary
chronic headache
% (95% CI)
n/N
Acupuncture 23 (15–35)
(15/65)
16 (8–27)
(9/58)
25 (7–59)
(2/8)
0 (0–43)
(0/5)
20 (14–27)
(26/133)
32 (17–52)
(8/25)
27 (10–57)
(3/11)
41 (22–64)
(7/17)
0 (0/1) 32 (20–46)
(15/47)
Chiropractic 23 (14–34)
(14/62)
28 (17–42)
(13/47)
25 (1/4) 50 (1/2) 26 (19–34)
(29/113)
30 (16–51)
(7/23)
38 (14–69)
(3/8)
43 (21–67)
(6/14)
- 38 (24–53)
(15/40)
Homeopathy 17 (1–37)
(4/23)
18 (6–41)
(3/17)
0 (0/2) 0 (0/3) 16 (8–29)
(7/44)
13 (2–47)
(1/8)
25 (1/4) 0 (0/7) - 6 (1–28)
(1/16)
Naprapathy 15(4–42)
(2/13)
17 (3–56)
(1/6)
- 0 (0/1) 15 (5–36)
(3/20)
33 (1/3) 0 (0/1) - - 33 (1/3)
Physiotherapy 23 (17–32)
(25/109)
28 (20–37)
(26/94)
25 (7–59)
(2/8)
25 (1/4) 25 (20–31)
(53/211)
43 (29–58)
(17/40)
28 (13–51)
(5/18)
41 (23–61)
(9/22)
33 (1/3) 38 (27–49)
(27/72)
Psychological
treatment
25 (1/4) 0 (0/3) - 0 (0/1) 25 (7–59)
(2/8)
0 (0/1) - 33 (1/3) - 33 (1/3)
Psychomotor
physiotherapy
29 (12–55)
(4/14)
41 (22–64)
(7/17)
- - 35 (21–53)
(11/31)
50 (1/2) 0 (0/1) 0 (0/1) - 25 (1/4)
Any alternative
treatment
39 (31–47)
(51/132)
42 (33–51)
(46/110)
33 (12–65)
(3/9)
33 (10–70)
(2/6)
40 (34–46)
(101/253)
51 (36–66)
(21/41)
37 (19–59)
(7/19)
50 (33–67)
(15/30)
33 (1/3) 46 (36–57)
(38/82)
Mean number of
CAM modalities
used (range)
2.3 (1–6) 2.3 (1–8) 2.6 (1–4) 3.2 (1–7) 2.4 (1–8) 2.7 (1–6) 2.5 (1–6) 2.4 (1–5) 1.3 (1–2) 2.5 (1–6)
CTTH; Chronic tension-type headache, CM; Chronic migraine, CPTH; Chronic post-traumatic headache, CEH; Cervicogenic headache, HACRS; Headache attributed to chronic rhinosinusitis.
Figures show percentages and numbers of patients who have report subjective efficacy of the given treatment (n) compared to the numbers who have tried the treatment (N). The diagnoses are not mutually
exclusive, i.e. one person can have two or more headache diagnoses. CI are not given when N <5.
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perceive CAM treatment as ineffective compared to epi-
sodic migraine patients [15], but we did not find any dif-
ference depending on medication overuse or not, so the
results from Italy might reflect a difference between
chronic and episodic headache sufferers. The efficacy re-
sults of any CAM treatment and the number of CAM
modalities used in our study indicate that the patients
seek a 2nd or 3rd CAM treatment, if the previous mo-
dality failed or had insufficient efficacy.
The placebo response in the management of headache
is approximately 30% in both pharmacological and non-
pharmacological clinical trials [18,19]. The self-reported
efficacy of CAM in our study is only slightly higher than
the placebo effect. The efficacy of acupuncture was bet-
ter in those with chronic tension-type headache (CTTH)
and co-occurrence of migraine than in CTTH without
co-occurrence of migraine. Otherwise we found no
significant differences in the CAM efficacy. A recent
Cochrane review of acupuncture for migraine prophy-
laxis [20] and a meta-analysis of manual therapies for
migraine and cervicogenic headache shows it is likely to
be as effective as prophylactic medication for migraine
[21,22]. Thus, CAM might have an effect in some types
of headaches.
Chronic headache is usually managed by medica-
tion, but medication may not always alleviate the
condition, and some people do not tolerate acute
and/or prophylactic medicine due to side effects or
contraindications. Finally, as shown in other studies
[15,16] some people may wish to avoid medication
due to possible side effects or risk for medication
overuse.
CAM might improve other health aspects than the
chronic headache for which treatment is being
sought. Thus, CAM may be a non-pharmacological
alternative option in the management of headache for
some people despite the contrast between the wide-
spread use of CAM and the lack of robust scientific
evidence for the efficacy of all these therapies.
Randomised controlled trials (RCTs) of CAM in
headache management are sparse and for certain
modalities there are no RCTs published in the litera-
ture. This indicates that there is a high and unmet
need for high-quality research in this field. New stud-
ies are needed and these should be methodologically
robust and follow the clinical trial guidelines from
IHS in order to provide data for the rationale of
CAM management in headache.
Conclusion
CAM is widely used, despite self-reported efficacy of dif-
ferent CAM modalities is modest in the management of
chronic headache.
Competing interest
All authors declare that they have no competing interests.
Authors’ contributions
MBR had the original idea for the study and planned the overall design. ESK
prepared the initial draft and was the main author of the present
manuscript. RBG and KA collected data. CL and MBR was involved in data
analysis and interpretation and assisted in preparation of the manuscript. All
authors have read, revised and approved the final manuscript.
Acknowledgments
Akershus University Hospital kindly provided research facilities.
Funding
This study was supported by grants from the East Norway and South East
Norway Regional Health Authority, Institute of Clinical Medicine, Campus
Akershus University Hospital, University of Oslo and Institute of Health and
Society, University of Oslo.
Author details
1Head and Neck Research Group, Research Centre, Akershus University
Hospital, Lørenskog, Norway. 2Department of General Practice, Institute of
Health and Society, University of Oslo, Oslo, Norway. 3Institute of Clinical
Medicine, Campus Akershus University Hospital, University of Oslo,
Nordbyhagen, Norway. 4Department of Neurology, Akershus University
Hospital, Lørenskog, Norway. 5HØKH, Research Centre, Akershus University
Hospital, Lørenskog, Norway.
Received: 25 January 2013 Accepted: 12 April 2013
Published: 18 April 2013
References
1. Grande RB, Aaseth K, Gulbrandsen P, Lundqvist C, Russell MB (2008)
Prevalence of primary chronic headache in a population-based sample of
30- to 44-year-old persons. The Akershus study of chronic headache.
Neuroepidemiology 30:76–83
2. Aaseth K, Grande RB, Kvaerner KJ, Gulbrandsen P, Lundqvist C, Russell MB
(2008) Prevalence of secondary chronic headaches in a population-based
sample of 30-44-year-old persons. The Akershus study of chronic headache.
Cephalalgia 28:705–713
3. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van RM et al (1998)
Trends in alternative medicine use in the United States, 1990–1997:
results of a follow-up national survey. JAMA 280:1569–1575
4. Fonnebo V, Launso L (2009) High use of complementary and alternative
medicine inside and outside of the government-funded health care system
in Norway. J Altern Complement Med 15:1061–1066
5. Statistics Norway (2012) The Norwegian Health Interview Survey.
http://www.ssb.no/a/samfunnsspeilet/utg/201002/05/tab-2010-05-03-03.
html Accessed 10-12-2012
6. Long L, Huntley A, Ernst E (2001) Which complementary and alternative
therapies benefit which conditions? A survey of the opinions of 223
professional organizations. Complement Ther Med 9:178–185
7. Headache Classification Subcommittee of the International Headache
Society (2004) The international classification of headache disorders:
2nd edition. Cephalalgia 24(Suppl 1):9–160
8. Aaseth K, Grande RB, Benth JS, Lundqvist C, Russell MB (2011) 3-Year
follow-up of secondary chronic headaches: the Akershus study of chronic
headache. Eur J Pain 15:186–192
9. The National Center for Complementary and Alternative Medicine (2012)
What is CAM. http://nccam.nih.gov/health/whatiscam Accessed 10-12-2012
10. Harris PE, Cooper KL, Elton C, Thomas KJ (2012) Prevalence of
complementary and alternative medicine (CAM) use by the general
population: a systematic review and update. Int J Clin Pract 66:924–939
11. Kristoffersen ES, Grande RB, Aaseth K, Lundqvist C, Russell MB (2012)
Management of primary chronic headache in the general population: the
Akershus study of chronic headache. J Headache Pain 13:113–120
12. Kristoffersen ES, Lundqvist C, Aaseth K, Grande RB, Russell MB (2013)
Management of secondary chronic headache in the general population.
The Akershus study of chronic headache. J Headache Pain 14:5
Kristoffersen et al. The Journal of Headache and Pain 2013, 14:36 Page 4 of 5
http://www.thejournalofheadacheandpain.com/content/14/1/36
13. Artus M, Croft P, Lewis M (2007) The use of CAM and conventional
treatments among primary care consulters with chronic musculoskeletal
pain. BMC Fam Pract 8:26
14. Rosenberg EI, Genao I, Chen I, Mechaber AJ, Wood JA, Faselis CJ, Kurz J,
Menon M, O’Rorke J, Panda M, Pasanen M, Staton L, Calleson D, Cykert S
(2008) Complementary and alternative medicine use by primary care
patients with chronic pain. Pain Med 9:1065–1072
15. Rossi P, Di LG, Malpezzi MG, Faroni J, Cesarino F, Di LC et al (2005)
Prevalence, pattern and predictors of use of complementary and alternative
medicine (CAM) in migraine patients attending a headache clinic in Italy.
Cephalalgia 25:493–506
16. Rossi P, Di LG, Faroni J, Malpezzi MG, Cesarino F, Nappi G (2006) Use of
complementary and alternative medicine by patients with chronic tension-
type headache: results of a headache clinic survey. Headache 46:622–631
17. Gaul C, Eismann R, Schmidt T, May A, Leinisch E, Wieser T, Evers S, Henkel K,
Franz G, Zierz S (2009) Use of complementary and alternative medicine in
patients suffering from primary headache disorders. Cephalalgia 29:1069–1078
18. de Groot FM, Voogt-Bode A, Passchier J, Berger MY, Koes BW, Verhagen AP
(2011) Headache: the placebo effects in the control groups in randomized
clinical trials; an analysis of systematic reviews. J Manipulative Physiol Ther
34:297–305
19. Speciali JG, Peres M, Bigal ME (2010) Migraine treatment and placebo effect.
Expert Rev Neurother 10:413–419
20. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR (2009)
Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev:
CD001218
21. Chaibi A, Tuchin PJ, Russell MB (2011) Manual therapies for migraine a
systematic review. J Headache Pain 12:127–133
22. Chaibi A, Russell MB (2012) Manual therapies for cervicogenic headache:
a systematic review. J Headache Pain 13:351–359
doi:10.1186/1129-2377-14-36
Cite this article as: Kristoffersen et al.: Self-reported efficacy of
complementary and alternative medicine: the Akershus study of chronic
headache. The Journal of Headache and Pain 2013 14:36.
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Kristoffersen et al. The Journal of Headache and Pain 2013, 14:36 Page 5 of 5
http://www.thejournalofheadacheandpain.com/content/14/1/36
